Location: International Region (preferably based in Europe, in particular the United Kingdom or Brussels, Belgium)
Function: Patient Advocacy & Policy
Contract type: Fulltime, permanent
The Opportunity
We are seeking a strategic, highly collaborative Director, International Patient Advocacy to lead the development and execution of impactful patient advocacy strategies across the International region. This role will focus primarily on Immunodeficiencies and Inflammatory Neuropathies and will play a critical part in advancing patient outcomes while supporting CSL's business priorities.
You will strengthen CSL's reputation and partnerships with key patient advocacy groups (PAGs) and other nonâgovernment stakeholders across Europe, Latin America, Asia, and the Middle East/Africa. You will serve as the primary liaison for aboveâmarket advocacy groups in the relevant disease areas and guide affiliate-level engagement to ensure alignment, consistency, and meaningful patient impact.
This role is central to elevating the patient voice - helping CSL better understand patient experiences, needs, and priorities and embedding these insights into how we develop and deliver therapies.
The Role
Strategic Leadership & Partnership Development
Cross Functional Collaboration & Expertise
Content Development & External Engagement
Governance & Compliance
Your Skills and Experience
Reporting Relationship
Role that this position reports to: Senior Director, Head of Global Patient Advocacy & Policy
Roles that report to this position: none
What we offer
We look forward to receiving your application.
#LI-MW1
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patientsâ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the worldâs largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
 To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
csl